John Matthew Mauro

Array ( [id] => 16776492 [patent_doc_number] => 20210113569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide [patent_app_type] => utility [patent_app_number] => 16/789655 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16252050 [patent_doc_number] => 20200261424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment of Diseases and Disorders Relating Thereto [patent_app_type] => utility [patent_app_number] => 16/748429 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95039 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16189681 [patent_doc_number] => 20200230530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => PLANT TRICHOME FILTRATION AND CONCENTRATION [patent_app_type] => utility [patent_app_number] => 16/745869 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16745869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16090137 [patent_doc_number] => 20200199055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => PROCESSES AND APPARATUS FOR EXTRACTION OF SUBSTANCES AND ENRICHED EXTRACTS FROM PLANT MATERIAL [patent_app_type] => utility [patent_app_number] => 16/742722 [patent_app_country] => US [patent_app_date] => 2020-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16549687 [patent_doc_number] => 10882836 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-05 [patent_title] => Method for purifying crude 2,5-furandicarboxylic acid composition [patent_app_type] => utility [patent_app_number] => 16/736263 [patent_app_country] => US [patent_app_date] => 2020-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2059 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16736263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18013260 [patent_doc_number] => 11505542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Preparation method for morpholinquinazoline compound and intermediates thereof [patent_app_type] => utility [patent_app_number] => 17/423153 [patent_app_country] => US [patent_app_date] => 2019-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8992 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18412030 [patent_doc_number] => 11666557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Triazolone compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 16/722773 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16025 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1086 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16572867 [patent_doc_number] => 10894780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-19 [patent_title] => Conversion of D9-THC to D10-THC [patent_app_type] => utility [patent_app_number] => 16/715368 [patent_app_country] => US [patent_app_date] => 2019-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2907 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17540955 [patent_doc_number] => 11306065 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-19 [patent_title] => Catalyst compositions for conversion of furfural to 2-methylfuran and their applications [patent_app_type] => utility [patent_app_number] => 16/703817 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4964 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15800053 [patent_doc_number] => 20200123169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => SELF-EXFOLIATED TRIAZOLE-TRIFORMYL PHLOROGLUCINOL BASED COVALENT ORGANIC NANOSHEETS FOR HIGH AND REVERSIBLE LITHIUM ION STORAGE [patent_app_type] => utility [patent_app_number] => 16/700481 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8461 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17513653 [patent_doc_number] => 11292782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => Diarylhydantoin compounds and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/698486 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 26602 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16695734 [patent_doc_number] => 10946306 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-16 [patent_title] => Solvent-based extraction methods [patent_app_type] => utility [patent_app_number] => 16/697733 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7630 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 360 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15681103 [patent_doc_number] => 20200095215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => PROCESS FOR THE PREPARATION OF SUBSTITUTED OXIRANES AND TRIAZOLES [patent_app_type] => utility [patent_app_number] => 16/694296 [patent_app_country] => US [patent_app_date] => 2019-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16694296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16741998 [patent_doc_number] => 10966965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Gaboxadol for reducing risk of suicide and rapid relief of depression [patent_app_type] => utility [patent_app_number] => 16/691049 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17806 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16741998 [patent_doc_number] => 10966965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Gaboxadol for reducing risk of suicide and rapid relief of depression [patent_app_type] => utility [patent_app_number] => 16/691049 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17806 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16741998 [patent_doc_number] => 10966965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Gaboxadol for reducing risk of suicide and rapid relief of depression [patent_app_type] => utility [patent_app_number] => 16/691049 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17806 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16741998 [patent_doc_number] => 10966965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Gaboxadol for reducing risk of suicide and rapid relief of depression [patent_app_type] => utility [patent_app_number] => 16/691049 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17806 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17399526 [patent_doc_number] => 20220041616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => SPIRO COMPOUND AND MEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/309270 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 568 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15993337 [patent_doc_number] => 20200172539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => Azalactam Compounds as HPK1 Inhibitors [patent_app_type] => utility [patent_app_number] => 16/679820 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16955946 [patent_doc_number] => 11059786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Aminopyridine compounds and methods for the preparation and use thereof [patent_app_type] => utility [patent_app_number] => 16/678700 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71132 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678700 [rel_patent_id] =>[rel_patent_doc_number] =>)